Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion type Assertion NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_head.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion description "[ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_provenance.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion evidence source_evidence_literature NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_provenance.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion SIO_000772 25413260 NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_provenance.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion wasDerivedFrom befree-2016 NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_provenance.
- NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_assertion wasGeneratedBy ECO_0000203 NP1238969.RAwsO1WEZaQdPBNd3kPmbbi41IDsNS4eK9QOXIp2vV5pw130_provenance.